Allowed use of vaccine developed by EU Johnson & Johnson

The EU-European Union has issued permission to use the new coronavirus vaccine developed by pharmaceutical giant Johnson & Johnson.

This is the fourth new coronavirus vaccine approved by the EU.

On the 11th, the European Union Pharmaceutical Agency of the EU reviewed the vaccine developed by pharmaceutical giant Johnson & Johnson and recommended that it issue a marketing license, which was received by the European Commission of the EU executive body on the same day. I put it out.

The EU has so far issued permits for vaccines such as Pfizer and AstraZeneca, and this is the fourth type of vaccine.

In a statement, European Commission Chairman Von der Leyen said, "This vaccine requires only one dose and is approaching our goal of inoculating 70% of adults by the end of summer. He expressed his hope that the inoculation in the region would gain momentum.

However, the supply of vaccines has been delayed across the board in the EU, and some member states are independently promoting vaccinations such as Russia, which the EU does not permit, and there are also situations where exports to the outside of the region are suspended. I'm awake.